Clinical trial
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
NCT00125749 · Baylor Research Institute, Other · Completed
Key facts
| NCT number | NCT00125749 |
|---|---|
| Title | Vaccination of Patients With Stage IV Melanoma With Dendritic Cells |
| Official title | Vaccination of Patients With Stage IV Melanoma With Dendritic Cells Generated Ex Vivo From Monocytes and Loaded With Heat Treated Killed Allogeneic Melanoma Cells |
| Lead sponsor | Baylor Research Institute, Other |
| Collaborators | Mary Crowley Medical Research Center ODC Therapy |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma, Neoplasm Metastasis |
| Intervention type | Biological |
| Interventions | Dendritic cell vaccination |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 2, 2005 |
| Last update posted | Jun 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: